By Sheri Kasprzak
New York, March 30 - Amarin Corp. plc has negotiated a $4,178,738 direct placement of American Depositary Shares.
The non-brokered offering includes 2,387,850 ADSs at $1.75 each, a 48% discount to the company's closing stock price of $3.37 on March 28.
Proceeds will be used for clinical trials, research and development expenses, working capital and general corporate purposes.
Located in London, Amarin is a biopharmaceutical company focused on treatments for neurological disorders and central nervous systems diseases.
| Issuer: | Amarin Corp. plc
|
| Issue: | American Depositary Shares
|
| Amount: | $4,178,738
|
| ADS: | 2,387,850
|
| Price: | $1.75
|
| Warrants: | No
|
| Placement agent: | Non-brokered
|
| Pricing date: | March 28
|
| Stock symbol: | Nasdaq: AMRN
|
| Stock price: | $3.37 at close March 28
|
| Stock price: | $3.26 at close March 30
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
